Astellas Pharma (Japan)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Japan), Japan, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
56%
Total
Publications
4.6K
Total Open
Publications
2.6K
Total
Citations
140K
Open Access
Percentage
56%
Total
Publications
4.6K
Total Open
Publications
2.6K
Total
Citations
140K
Breakdown
Publisher Open
26%
Both
23%
Other Platform Open
7%
Closed
44%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 22%
504
Hybrid 42%
957
No Guarantees 36%
821
Other Platform Open
Domain 85%
1.2K
Institution 22%
307
Public 11%
150
Other Internet 6%
83
Preprint 4%
53
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.2K |
Europe PMC | Domain | 709 |
Semantic Scholar | Public | 120 |
DOI | Other Internet | 65 |
Figshare | Public | 61 |
University College London - UCL Discovery | Institution | 31 |
Research Square | Preprint | 27 |
Radboud University - Radboud Repository | Institution | 25 |
California Digital Library - eScholarship | Other Internet | 24 |
KU Leuven - Lirias | Institution | 23 |